|
Brain Changes in Fear Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Brain Changes in Fear conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Brain Changes in Fear Clinical research trials and Brain Changes in Fear medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Brain Changes in Fear. Brain Changes in Fear Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Brain Changes in Fear clinical trial. Subjects often receive the most expert healthcare possible for their Brain Changes in Fear condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Brain Changes in Fear  Brain Changes in Fear
Brain Changes in Fear
For Condition: Anxiety Disorders
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to use brain imaging technology to investigate brain changes in people exposed to predictable versus unpredictable unpleasant stimuli. Unpleasant events that can be predicted evoke a response of fear, whereas unpredictable, unpleasant stimuli cause chronic anxiety not associated with a specific event. Information gained from this study may help in the development of more effective treatments for anxiety disorders. When confronted with fearful events, people eventually develop fear of specific cues that were associated with these events as well as to the environmental context in which the fearful event occurred. Evidence suggests that cued fear and contextual fear model different aspects of anxiety. However, studies that examine the way the brain affects expression of contextual fear have not been conducted. This study will use magnetic resonance imaging (MRI) or Magneto-encephalography (MEG) to compare the brain activity underlying fear brought on by predictable and unpredictable aversive stimuli.
Details: During fear conditioning in which a phasic explicit (e.g., a light) is repeatedly associated with an aversive unconditioned stimulus (e.g., a shock), the organism develops fear to the explicit cue as well as to the environmental context in which the experiment took place. Experimental evidence suggests that cued fear and contextual fear model different aspects of anxiety. Studies in patients indicated that contextual fear may model an aspect that is especially relevant to anxiety disorders (Grillon et al.,1994, 1998a,b; 1999). However, the neural basis for the expression of contextual fear has not previously been elucidated in human imaging studies. One important determinant of contextual fear is predictability: contextual fear increases when a treat (e.g., electric shock) is unpredictable, as opposed to when the treat is predictable. The aim of this study is to compare the neural substrates underlying fear evoked by predictable versus unpredictable shocks. Animal studies have indicated that conditioned responses to predictably cued threat and to less explicit threat are separate processes mediated by distinct brain structures. Psychophysiological data suggest that the proposed procedure can differentiate between these two responses. Hence, we anticipate that this procedure will allow us to compare brain correlates of these responses in humans.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA Male or female volunteers ages 18-40 years old. Judged to be in good physical and psychiatric health on the basis of medical history, a clinical MRI scan, and physical examination. Able to understand procedures and agree to participate in the study by giving written informed consent. EXCLUSION CRITERIA Clinically significant organ disease, e.g., cardiovascular. Clinically significant abnormalities in physical examination. Any medical condition that increases risk for fMRI (e.g. pacemaker, metallic foreign body in eye). History of any disease, which in the investigators' opinion may confound the results of the study, including, but not limited to, history of organic mental disorders, seizure, or mental retardation. Lifetime history of substance dependence, or substance abuse within past 1 year. Current Axis I psychiatric disorders as identified with the Structured Clinical Interview for DSM-IV-TR axis disorders, non-patient edition (SCID-np). Psychotropic medication within 4 weeks of scanning. Pregnancy, i.e., a positive beta-HCG urine test.
Total Enrollment: 44
Location and Contact Information:
National Institute of Mental Health (NIMH) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 020321; 02-M-0321
Study Start Date: October 11, 2002
Record last reviewed: July 31, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00047853
Other Anxiety Disorders Studies:
1. Preventing Anxiety Disorders in Youth
2. Pharmacologic Treatment of PTSD in Sexually Abused Children
3. Reward-Related Processes and Brain Function
4. Cognitive and Drug Therapy for Drug-Resistant Depression
5. Treatment for Anxiety in Children
Related Studies:
Other Anxiety Disorders Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Brain Changes in Fear
|
|
|
|
|
|
|
|
